Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

418.44
Delayed Data
As of Mar 02
 +4.60 / +1.11%
Today’s Change
269.50
Today|||52-Week Range
437.64
+2.00%
Year-to-Date

Today’s Trading

Previous close413.84
Today’s open416.28
Day’s range414.17 - 419.60
Volume614,013
Average volume (3 months)831,477
Market cap$42.5B
Dividend yield--
Data as of 4:00pm ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+4.30%
Earnings growth (next 5 years)+15.72%
Revenue growth (last year)+33.96%
P/E ratio136.3
Price/Sales14.64
Price/Book16.67

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+3.87+3.81%
ISISIsis Pharmaceuticals...-1.76-2.57%
QQuintiles Transnatio...0.000.00%
ICLRICON PLC+0.40+0.58%
Data as of 4:00pm ET, 03/02/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.70
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account